14 results match your criteria Noncandidal Fungal Infections of the Mouth

  • Page 1 of 1

[Nondermatophytic and noncandidal fungi isolated in Le Dantec University hospital of Dakar in 2014: Epidemiological, clinical and mycological study].

J Mycol Med 2015 Sep 29;25(3):181-90. Epub 2015 Jun 29.

Laboratoire de parasitologie-mycologie, CHU Aristide Le Dantec, Dakar, Sénégal; Laboratoire de parasitologie-mycologie, faculté de médecine, de pharmacie et d'odontologie, université Cheikh Anta Diop, Dakar, Sénégal.

In recent years, the incidence of superficial fungal infections involving nondermatophytic and noncandidal fungi increased considerably. The objective of this work was to analyze the epidemiological, clinical and mycological fungal infections due to nondermatophytic and noncandidal fungi diagnosed in the laboratory of parasitology-mycology of Le Dantec hospital in Dakar. With a retrospective study of the various cases of nondermatophytic and noncandidal fungi isolated in the laboratory of parasitology-mycology during the period of November 2013 to December 2014, we collected 22 cases of infections in 11 men and 11 women; age ranging from 17 to 75 years with a mean of 45. Read More

View Article
September 2015
12 Reads

[Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].

Korean J Lab Med 2010 Aug;30(4):364-72

Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

Background: We utilized results from the ARTEMIS DISK Global Antifungal Surveillance Program to evaluate the species distribution and fluconazole and voriconazole susceptibilities of yeast isolates from clinical specimens in South Korea from 2001 to 2007.

Methods: Data were collected on 5,665 yeast isolates from all body sites at three locations. All investigators tested clinical yeast isolates using the CLSI M44-A disk diffusion method. Read More

View Article
August 2010
3 Reads

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

J Clin Microbiol 2009 Jan 12;47(1):117-23. Epub 2008 Nov 12.

Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA.

Fluconazole in vitro susceptibility test results determined by the CLSI M44-A disk diffusion method for 11,240 isolates of noncandidal yeasts were collected from 134 study sites in 40 countries from June 1997 through December 2007. Data were collected for 8,717 yeast isolates tested with voriconazole from 2001 through 2007. A total of 22 different species/organism groups were isolated, of which Cryptococcus neoformans was the most common (31. Read More

View Article
January 2009
4 Reads

Candida spp. urinary tract infections in 13 dogs and seven cats: predisposing factors, treatment, and outcome.

J Am Anim Hosp Assoc 2003 May-Jun;39(3):263-70

Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, North Carolina 27606, USA.

Records from 20 animals (13 dogs, seven cats) with Candida spp. urinary tract infections were reviewed. Six Candida spp. Read More

View Article
June 2003
3 Reads

Management of systemic candidal infections in the intensive care unit.

Am J Health Syst Pharm 2002 Jan;59(1):33-41

James A. Haley Veterans Affairs Medical Center, Pharmacy Department (119), 13000 Bruce B. Downs Boulevard, Tampa, FL 33612, USA.

Risk factors and treatment strategies for systemic candidal infections in the intensive care unit (ICU) are discussed. The past two decades have seen a dramatic increase in the frequency of infections caused by Candida species. Risk factors associated with candidemia include treatment with multiple antimicrobials for extended periods, presence of central venous catheters, total parenteral nutrition, colonization by Candida species, abdominal surgery, prolonged stay in the ICU, and compromised immune status. Read More

View Article
January 2002
2 Reads

Vulvitis attributed to hypersensitivity to estrogen. A report of 11 cases.

J Reprod Med 2000 Jun;45(6):493-7

Department of Women's and Childrens' Health, Nepean Hospital, Penrith, NSW, Australia.

Background: Vulvitis that is refractory to all treatment remains a therapeutic challenge. Hypersensitivity to progesterone and estrogen has been recognized as a rare cause of premenstrual dermatoses. Such hypersensitivity seemed to be the cause of vulvitis in the patients described below. Read More

View Article
June 2000
1 Read

Antifungal prophylaxis during neutropenia and immunodeficiency.

Clin Microbiol Rev 1997 Jul;10(3):477-504

Service de Médecine Interne, Hôpital Avicenne, Université Paris-Nord, Bobigny, France.

Fungal infections represent a major source of morbidity and mortality in patients with almost all types of immunodeficiencies. These infections may be nosocomial (aspergillosis) or community acquired (cryptococcosis), or both (candidiasis). Endemic mycoses such as histoplasmosis, coccidioidomycosis, and penicilliosis may infect many immunocompromised hosts in some geographic areas and thereby create major public health problems. Read More

View Article
July 1997
1 Read

Noncandidal fungal peritonitis in patients with AIDS: report of three cases and review.

Clin Infect Dis 1997 Feb;24(2):279-80

Veterans Affairs Medical Center, Houston, Department of Medicine, Baylor College of Medicine, Texas 77030-4211, USA.

View Article
February 1997
1 Read

Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation.

Transfusion 1994 Mar;34(3):226-32

Division of Pediatric Hematology-Oncology, University of Minnesota, Minneapolis.

Background: A retrospective study was conducted to evaluate the efficacy of granulocyte transfusions in neutropenic patients with fungal infections following bone marrow transplantation.

Study Design And Methods: Systemic fungal infection was detected in 87 patients during the first 100 days following bone marrow transplantation; 50 received granulocytes in addition to appropriate antifungal agents. The median age was 17 years in the transfused patients (range, 1. Read More

View Article
March 1994
4 Reads

Noncandidal, fungal infections of the burn wound.

J Burn Care Rehabil 1988 Nov-Dec;9(6):599-601

Division of Plastic Surgery, Ohio State University, Columbus.

Candidal (yeast) and noncandidal (filamentous fungal) wound infections have become an increasingly important cause of burn-associated morbidity and mortality. However, these two diseases differ markedly in their epidemiology, onset, appearance, diagnosis, and treatment. In the last four years, we have had five cases of noncandidal sepsis (four mucoraceae and one aspergillus) that are illustrative of these differences. Read More

View Article
March 1989
1 Read

Hansenula anomala: a new fungal pathogen. Two case reports and a review of the literature.

Arch Intern Med 1988 May;148(5):1210-3

Department of Medicine, School of Allied Health Professions, State University of New York, Stony Brook 11794-8153.

Fungal infections are characteristic of severely immunocompromised patients. Noncandidal yeasts represent a growing proportion of such infections. Risk factors for developing fungal infections include the use and abuse of central venous catheters. Read More

View Article
May 1988
1 Read

Candidal antigen detection in pulmonary candidiasis.

Am J Med 1983 Apr;74(4):630-40

To better characterize pulmonary candidiasis, lung tissue samples from 58 hospital subjects were examined by immunohistochemical analysis with antiserums to candidal mannan and cytoplasmic antigens. In nine cases of invasive pulmonary candidiasis, fungal antigens were abundant in lung specimens and were distributed in two immunohistologic patterns. Antigen dissemination beyond the lung was confirmed by detection of antigenemia by mannan radioimmunoassay in serum samples in cases of pulmonary candidiasis of each immunohistologic pattern. Read More

View Article
April 1983
1 Read

Improved survival with aggressive surgical management of noncandidal fungal infections of the burn wound.

J Trauma 1982 Oct;22(10):867-8

A period of aggressive surgical treatment of early identification of fungal infection of the burn wound was compared with the previous 5 years' experience with patients suffering from fungal infection of burn wounds. The portion of those patients with Candida infections diagnosed and treated premortem increased from 48.0% to 63. Read More

View Article
October 1982
1 Read

The emergence of candidosis. The dominant postmortem cerebral mycosis.

Am J Clin Pathol 1978 Jul;70(1):31-6

Comparable human postmortem surveys in central Kentucky and southern Florida have demonstrated an altered pattern of cerebral mycoses due primarily to therapeutic manipulations. From both states 8,975 complete autopsies yielded 39 patients with histologically verified cerebral mycoses. The most common infection was candidosis (49%), characterized by intraparenchymal microabscesses without significant leptomeningitis in hospitalized patients compromised by antibiotic therapy for infection with gram-negative organisms. Read More

View Article
July 1978
1 Read
  • Page 1 of 1